Pharmaceutical & Specialty Chemicals

Bioactive methyl form of Vitamin B12 for neurological tablet, injectable, and nutraceutical formulations. Pharmaceutical-grade API with confirmed methylcobalamin potency and light-sensitivity specifications.

Leukotriene receptor antagonist API for oral tablet and granule formulations in asthma and allergic rhinitis management. Amorphous sodium salt with confirmed residual solvent and polymorph documentation.

Proton pump inhibitor sodium sesquihydrate API in sterile grade for lyophilised injectable vial manufacture. Endotoxin-tested with sterility documentation for hospital-grade IV formulations.

Pantoprazole sodium meeting USP pharmacopoeial monograph for oral delayed-release tablet and IV formulations. Preferred for FDA-regulated and North American export pharmaceutical supply.

Acetaminophen analgesic/antipyretic API in IP-grade crystalline and granular forms for tablet, capsule, and syrup formulations. High-volume traded API with full COA and dissolution clearance.

Sterile-grade combination of piperacillin sodium and tazobactam sodium for injectable formulation manufacture. IP-compliant sterile API blend with endotoxin testing and sterility documentation.

USP-grade sterile piperacillin-tazobactam combination API for US-regulated injectable formulation. Supplied with full endotoxin and sterility clearance for large-volume antibiotic injectable production.

European Pharmacopoeia–grade GABA analogue for anticonvulsant and neuropathic pain capsule formulations. Full impurity profile control to Ph.Eur standards for European regulated market supply.

IP pharmacopoeial–grade pregabalin for domestic and export capsule and oral solution formulations. Supplied with confirmed chiral purity, particle size, and dissolution performance data.

Benzimidazole proton pump inhibitor API for oral enteric-coated tablet formulations. Traded in refined crystalline grade with documented impurity profile and polymorph consistency.

HMG-CoA reductase inhibitor calcium salt API for oral tablet formulations. IP-grade with confirmed polymorphic form and low-dose tablet suitability for statin therapy supply.

Bacterial serine protease enzyme API in enteric-form used in anti-inflammatory tablet formulations. Traded in IP-grade with confirmed enzymatic potency (SPU/mg) per pharmacopoeial standards.

High-intensity sweetener (600× sucrose) for pharmaceutical and nutraceutical formulations requiring calorie-free sweetening. Supplied in standard purity grade for direct blending in oral dosage forms.

Consumer and formulation-grade sucralose blend suitable for oral liquid, chewable, and powder dosage forms. Provides consistent taste masking in paediatric and diabetic-friendly formulations.

Technical-grade sucralose for large-volume pharmaceutical manufacturing processes. Optimised for blendability and flowability in high-throughput granulation and direct compression operations.

Beta-lactamase inhibitor sterile sodium salt API, dual pharmacopoeial–compliant (IP/USP) for injectable combination antibiotic formulations. Full sterility and endotoxin clearance documentation provided.

Beta-lactamase inhibitor API in sodium salt form for injectable combination antibiotic formulation manufacture. IP-grade with both sterile and non-sterile grades available for flexible supply.